{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:29:40Z","timestamp":1740166180974,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T00:00:00Z","timestamp":1656201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T00:00:00Z","timestamp":1656201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s13760-022-01960-x","type":"journal-article","created":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T07:04:41Z","timestamp":1656227081000},"page":"1237-1245","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel prognostic system based on clinical and laboratory parameters for childhood Guillain\u2013Barre syndrome"],"prefix":"10.1007","volume":"122","author":[{"given":"Ishita","family":"Tiwari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8564-7051","authenticated-orcid":false,"given":"Areesha","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandra","family":"kanta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sciddhartha","family":"Koonwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravindra Kumar","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shweta","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amita","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmi","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,26]]},"reference":[{"key":"1960_CR1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000184748","volume":"32","author":"A McGrogan","year":"2009","unstructured":"McGrogan A, Madle GC, Seaman HE, de Vries CS (2009) The epidemiology of Guillain-Barr\u00e9 syndrome worldwide. A systematic literature review. Neuroepidemiology 32:150\u2013163","journal-title":"Neuroepidemiology"},{"key":"1960_CR2","doi-asserted-by":"publisher","first-page":"6517","DOI":"10.1128\/IAI.00967-06","volume":"74","author":"KY Robert","year":"2006","unstructured":"Robert KY, Usuki S, Ariga T (2006) Ganglioside molecular mimicry and its pathological roles in Guillain-Barre syndrome and related diseases. Infect Immun 74:6517\u20136527","journal-title":"Infect Immun"},{"key":"1960_CR3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","volume":"10","author":"B Van den Berg","year":"2014","unstructured":"Van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA (2014) Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol 10:469\u2013482","journal-title":"Nat Rev Neurol"},{"key":"1960_CR4","doi-asserted-by":"publisher","first-page":"426","DOI":"10.31925\/farmacia.2020.3.7","volume":"68","author":"A Stoian","year":"2020","unstructured":"Stoian A, Mo\u021b\u0103\u021b\u0103ianu A, B\u0103rcu\u021bean L et al (2020) Understandig the mechanism of action of intravenous immunoglobulins: a ten years experience in treating guillain-barr\u00e9 syndrome. Farmacia 68:426\u2013435","journal-title":"Farmacia"},{"key":"1960_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1177\/0883073820978020","volume":"36","author":"I Tiwari","year":"2021","unstructured":"Tiwari I, Alam A, Kanta C et al (2021) Clinical profile and predictors of mechanical ventilation in Guillain-Barre syndrome in North Indian Children. J Child Neurol 36:453\u2013460","journal-title":"J Child Neurol"},{"key":"1960_CR6","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1136\/adc.62.7.733","volume":"62","author":"DM Briscoe","year":"1987","unstructured":"Briscoe DM, McMenamin JB, O\u2019Donohoe NV (1987) Prognosis in Guillain-Barre syndrome. Arch Dis Child 62:733\u2013735","journal-title":"Arch Dis Child"},{"key":"1960_CR7","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1136\/jnnp-2011-301882","volume":"83","author":"YA Rajabally","year":"2012","unstructured":"Rajabally YA, Uncini A (2012) Outcome and its predictors in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 83:711\u2013718","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1960_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1001\/jamaneurol.2016.4480","volume":"74","author":"WJR Fokkink","year":"2017","unstructured":"Fokkink WJR, Walgaard C, Kuitwaard K et al (2017) Association of albumin levels with outcome in intravenous immunoglobulin-treated Guillain-Barr\u00e9 syndrome. JAMA Neurol 74:189\u2013196","journal-title":"JAMA Neurol"},{"key":"1960_CR9","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.2147\/NDT.S162896","volume":"14","author":"O Ethemoglu","year":"2018","unstructured":"Ethemoglu O, Calik M (2018) Effect of serum inflammatory markers on the prognosis of adult and pediatric patients with Guillain-Barr\u00e9 syndrome. Neuropsychiatr Dis Treat 14:1255\u20131260","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1960_CR10","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1590\/0004-282X20160132","volume":"74","author":"HH Ozdemir","year":"2016","unstructured":"Ozdemir HH (2016) Analysis of the albumin level, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio in Guillain-Barre syndrome. Arq Neuropsiquiatr 74:718\u2013722","journal-title":"Arq Neuropsiquiatr"},{"key":"1960_CR11","doi-asserted-by":"publisher","first-page":"7032","DOI":"10.4081\/ni.2017.7032","volume":"9","author":"S Sahin","year":"2017","unstructured":"Sahin S, Cinar N, Karsidag S (2017) Are cerebrospinal fluid protein levels and plasma neutrophil\/lymphocyte ratio associated with prognosis of Guillain Barr\u00e9 syndrome? Neurol Int 9:7032","journal-title":"Neurol Int"},{"issue":"2","key":"1960_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1177\/0883073817748109","volume":"33","author":"EA H\u00fcner","year":"2018","unstructured":"H\u00fcner EA, Dai AI, Demiry\u00fcrek AT (2018) Association of neutrophil\/lymphocyte ratio with intravenous immunoglobulin treatment in children with Guillain-Barr\u00e9 syndrome. J Child Neurol 33(2):164\u2013167","journal-title":"J Child Neurol"},{"issue":"4","key":"1960_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.26815\/acn.2019.00143","volume":"27","author":"SH Kim","year":"2019","unstructured":"Kim SH, Samadov F, Mukhamedov A (2019) Clinical characteristics and prognostic factors of children with Guillain-Barr\u00e9 syndrome. Ann Child Neurol 27(4):113\u2013119","journal-title":"Ann Child Neurol"},{"key":"1960_CR14","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1007\/s11739-012-0802-0","volume":"7","author":"A Gatta","year":"2012","unstructured":"Gatta A, Verardo A, Bolognesi M (2012) Hypoalbuminemia. Intern Emerg Med 7:S193\u2013S199","journal-title":"Intern Emerg Med"},{"issue":"5","key":"1960_CR15","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.nefro.2016.12.006","volume":"37","author":"V Ch\u00e1vez Valencia","year":"2017","unstructured":"Ch\u00e1vez Valencia V, Orizaga de la Cruz C, Mej\u00eda Rodr\u00edguez O et al (2017) Inflammation in hemodialysis and their correlation with neutrophil-lymphocyte ratio and platelet- lymphocyte ratio. Nefrologia 37(5):554\u2013556","journal-title":"Nefrologia"},{"key":"1960_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S1474-4422(07)70130-8","volume":"6","author":"R Van Koningsveld","year":"2007","unstructured":"Van Koningsveld R, Steyerberg EW, Hughes RA et al (2007) A clinical prognostic scoring system for Guillain Barr\u00e9 syndrome. Lancet Neurol 6:589\u2013594","journal-title":"Lancet Neurol"},{"key":"1960_CR17","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1212\/WNL.61.6.736","volume":"61","author":"RA Hughes","year":"2003","unstructured":"Hughes RA, Wijdicks EF, Barohn R et al (2003) Quality standards subcommittee of the American academy of neurology. Practice parameter: immunotherapy for Guillain-Barr\u00e9 syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 61:736\u2013740","journal-title":"Neurology"},{"key":"1960_CR18","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ana.410440512","volume":"44","author":"RD Hadden","year":"1998","unstructured":"Hadden RD, Cornblath DR, Hughes RA et al (1998) Plasma exchange\/sandoglobulin Guillain-Barr\u00e9 syndrome trial group. Electrophysiological classification of Guillain-Barr\u00e9 syndrome: clinical associations and outcome. Ann Neurol 44:780\u2013788","journal-title":"Ann Neurol"},{"key":"1960_CR19","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","volume":"29","author":"JJ Sejvar","year":"2011","unstructured":"Sejvar JJ, Kohl KS, Gidudu J et al (2011) Guillain-Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 29:599\u2013612","journal-title":"Vaccine"},{"key":"1960_CR20","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","volume":"312","author":"RAC Hughes","year":"1978","unstructured":"Hughes RAC, Newsom-Davis JM, Perkin GD, Pierce JM (1978) Controlled trial of prednisolone in acute polyneuropathy. The Lancet 312:750\u2013753","journal-title":"The Lancet"},{"key":"1960_CR21","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1111\/imj.14705","volume":"50","author":"SL Barnes","year":"2020","unstructured":"Barnes SL, Herkes GK (2020) Guillain-Barr\u00e9 syndrome: clinical features, treatment choices and outcomes in an Australian cohort. Intern Med J 50:1500\u20131504","journal-title":"Intern Med J"},{"key":"1960_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jocn.2020.01.032","volume":"72","author":"J Kalita","year":"2020","unstructured":"Kalita J, Kumar M, Misra UK (2020) Serial single breath count is a reliable tool for monitoring respiratory functions in Guillain-Barr\u00e9 Syndrome. J Clin Neurosci 72:50\u201356","journal-title":"J Clin Neurosci"},{"key":"1960_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jns.2013.09.002","volume":"335","author":"R Verma","year":"2013","unstructured":"Verma R, Chaudhari TS, Raut TP, Garg RK (2013) Clinico-electrophysiological profile and predictors of functional outcome in Guillain-Barre syndrome. J Neurol Sci 335:105\u2013111","journal-title":"J Neurol Sci"},{"key":"1960_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jocn.2018.11.031","volume":"62","author":"SH Siddiqui","year":"2019","unstructured":"Siddiqui SH, Siddiqui TH, Babar MU, Khoja A, Khan S (2019) Outcomes of patients with Guillain Barre syndrome\u2014experience from a tertiary care hospital of a developing Asian country and review of regional literature. J Clin Neurosci 62:195\u2013198","journal-title":"J Clin Neurosci"},{"key":"1960_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/mus.23477","volume":"47","author":"Y Ye","year":"2013","unstructured":"Ye Y, Wang K, Deng F, Xing Y (2013) Electrophysiological subtypes and prognosis of Guillain-Barr\u00e9 syndrome in Northeastern China. Muscle Nerve 47:68\u201371","journal-title":"Muscle Nerve"},{"key":"1960_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.nic.2013.03.023","volume":"24","author":"T Chung","year":"2014","unstructured":"Chung T, Prasad K, Lloyd TE (2014) Peripheral neuropathy: clinical and electrophysiological considerations. Neuroimaging Clin N Am 24:49\u201365","journal-title":"Neuroimaging Clin N Am"},{"key":"1960_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0165-5728(99)00195-2","volume":"100","author":"RA Hughes","year":"1999","unstructured":"Hughes RA, Hadden RD, Gregson NA, Smith KJ (1999) Pathogenesis of Guillain-Barr\u00e9 syndrome. J Neuroimmunol 100:74\u201397","journal-title":"J Neuroimmunol"},{"key":"1960_CR28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00415-016-8204-2","volume":"264","author":"J Berciano","year":"2017","unstructured":"Berciano J, Sedano MJ, Pelayo-Negro AL et al (2017) Proximal nerve lesions in early Guillain-Barr\u00e9 syndrome: implications for pathogenesis and disease classification. J Neurol 264:221\u2013236","journal-title":"J Neurol"},{"key":"1960_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000243086","volume":"17","author":"CL De La Hoz","year":"2010","unstructured":"De La Hoz CL, Castro FR, Santos LM et al (2010) Distribution of inducible nitric oxide synthase and tumor necrosis factoralpha in the peripheral nervous system of Lewis rats during ascending paresis and spontaneous recovery from experimental autoimmune neuritis. NeuroImmunoModulation 17:56\u201366","journal-title":"NeuroImmunoModulation"},{"key":"1960_CR30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12974-017-1001-8","volume":"14","author":"D Schafflick","year":"2017","unstructured":"Schafflick D, Kieseier BC, Wiendl H, Horste GM (2017) Novel pathomechanisms in inflammatory Neuropathies. J Neuroinflammation 14:232\u2013249","journal-title":"J Neuroinflammation"},{"key":"1960_CR31","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/ilar\/ilt054","volume":"54","author":"B Soliven","year":"2014","unstructured":"Soliven B (2014) Animal models of autoimmune neuropathy. ILAR J 54:282\u2013290","journal-title":"ILAR J"},{"key":"1960_CR32","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1001\/jamaneurol.2014.1129","volume":"71","author":"Chi\u00f2 A, Calvo A, Bovio G, et al. Register for Amyotrophic Lateral Sclerosis","year":"2014","unstructured":"Chi\u00f2 A, Calvo A, Bovio G, et al. Register for Amyotrophic Lateral Sclerosis (2014) Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study. JAMA Neurol 71:1134\u20131142","journal-title":"JAMA Neurol"},{"key":"1960_CR33","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10072-014-1976-1","volume":"36","author":"E Ak\u0131l","year":"2015","unstructured":"Ak\u0131l E, Bulut A, Kaplan \u0130 et al (2015) The increase of carcinoembryonic antigen (CEA), high-sensitivityC-reactive protein, andneutrophil\/lymphocyte ratioin Parkinson\u2019s disease. Neurol Sci 36:423\u2013428","journal-title":"Neurol Sci"},{"key":"1960_CR34","first-page":"162","volume":"3","author":"YG Aras","year":"2015","unstructured":"Aras YG, Gungen BD, Kotan D (2015) Neutrophil\/Lymphocyte ratio in migraine patients and \u0131ts correlation with aura. Ajans 3:162\u2013166","journal-title":"Ajans"},{"key":"1960_CR35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1044\/persp1.SIG3.94","volume":"1","author":"A Lewandowski","year":"2016","unstructured":"Lewandowski A, Gillespie AI (2016) The relationship between voice and breathing in the assessment and treatment of voice disorders. Perspect ASHA Spec Interest Groups 1:94","journal-title":"Perspect ASHA Spec Interest Groups"},{"key":"1960_CR36","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","volume":"76","author":"C Walgaard","year":"2011","unstructured":"Walgaard C, Lingsma HF, Ruts L et al (2011) Early recognition of poor prognosis in Guillain-Barr\u00e9 syndrome. Neurology 76:968\u2013975","journal-title":"Neurology"},{"key":"1960_CR37","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1159\/000210548","volume":"61","author":"M K\u00f6hrmann","year":"2009","unstructured":"K\u00f6hrmann M, Huttner HB, Nowe T et al (2009) Mechanical ventilation in Guillain-Barr\u00e9 syndrome: does age influence functional outcome? Eur Neurol 61:358\u2013363","journal-title":"Eur Neurol"},{"issue":"4","key":"1960_CR38","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/jns.12286","volume":"23","author":"C Walgaard","year":"2018","unstructured":"Walgaard C, Jacobs BC, Lingsma HF et al (2018) Second IVIg course in Guillain-Barre syndrome patients with poor prognosis (SID-GBS trial): protocol for a double-blind randomized, placebocontrolled clinical trial. J Peripher Nerv Syst 23(4):210\u2013215","journal-title":"J Peripher Nerv Syst"},{"key":"1960_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jocn.2020.01.067","volume":"74","author":"A Shalman","year":"2020","unstructured":"Shalman A, Savir S, Mechnik Steen Y et al (2020) Albumin levels as a biomarker for second Intravenous Immunoglobulin (IVIG) treatment in Guillain-Barre syndrome (GBS). J Clin Neurosci 74:247\u2013249","journal-title":"J Clin Neurosci"},{"key":"1960_CR40","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1093\/brain\/119.6.2053","volume":"119","author":"Italian Guillain-Barr\u00e9 Study Group","year":"1996","unstructured":"Italian Guillain-Barr\u00e9 Study Group (1996) The prognosis and main prognostic indicators of Guillain-Barre syndrome A multicentre prospective study of 297 patients. Brain 119:2053\u20132061","journal-title":"Brain"},{"key":"1960_CR41","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.19082\/3318","volume":"8","author":"AA Sadek","year":"2016","unstructured":"Sadek AA, Abou-Taleb A, Ali WA (2016) Outcome of Guillain-Barr\u00e9 syndrome in children: a prospective cohort study in a tertiary hospital in upper Egypt. Electron Phys 8:3318\u20133324","journal-title":"Electron Phys"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-022-01960-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-022-01960-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-022-01960-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T11:07:20Z","timestamp":1664104040000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-022-01960-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,26]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1960"],"URL":"https:\/\/doi.org\/10.1007\/s13760-022-01960-x","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"type":"print","value":"0300-9009"},{"type":"electronic","value":"2240-2993"}],"subject":[],"published":{"date-parts":[[2022,6,26]]},"assertion":[{"value":"18 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Taken.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Yes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}